Chinese Herbal Medicines最新文献

筛选
英文 中文
Hypoglycemic activities of flowers of Xanthoceras sorbifolia and identification of anti-oxidant components by off-line UPLC-QTOF-MS/MS-free radical scavenging detection 文冠花的降血糖活性及抗氧化成分的离线UPLC-QTOF-MS/MS自由基清除检测
IF 3.8 4区 医学
Chinese Herbal Medicines Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2022.11.009
Xiajing Xu , Yongli Guo , Menglin Chen , Ning Li , Yi Sun , Shumeng Ren , Jiao Xiao , Dongmei Wang , Xiaoqiu Liu , Yingni Pan
{"title":"Hypoglycemic activities of flowers of Xanthoceras sorbifolia and identification of anti-oxidant components by off-line UPLC-QTOF-MS/MS-free radical scavenging detection","authors":"Xiajing Xu ,&nbsp;Yongli Guo ,&nbsp;Menglin Chen ,&nbsp;Ning Li ,&nbsp;Yi Sun ,&nbsp;Shumeng Ren ,&nbsp;Jiao Xiao ,&nbsp;Dongmei Wang ,&nbsp;Xiaoqiu Liu ,&nbsp;Yingni Pan","doi":"10.1016/j.chmed.2022.11.009","DOIUrl":"10.1016/j.chmed.2022.11.009","url":null,"abstract":"<div><h3>Objective</h3><p>To identify phytochemical constituents present in the extract of flowers of <em>Xanthoceras sorbifolia</em> and evaluate their anti-oxidant and anti-hyperglycemic capacities.</p></div><div><h3>Methods</h3><p>The AlCl<sub>3</sub> colorimetric method and Prussian Blue assay were used to determine the contents of total flavonoids and total phenolic acids in extraction layers, and the bioactive layers was screened through anti − oxidative activity <em>in vitro</em>. The Waters ACQUITY UPLC system and a Waters ACQUITY UPLC BEH C<sub>18</sub> column (2.0 mm × 150 mm, 5 μm) were used to identify the ingredients. And anti-oxidative ingredients were screened by off-line UPLC-QTOF-MS/MS-free radical scavenging. The ameliorative role of it was further evaluated in a high-fat, streptozotocin-induced type 2 diabetic rat model and the study was carried out on NADPH oxidase (PDB ID: 2CDU) by molecular docking.</p></div><div><h3>Results</h3><p>Combined with the results of activity screening <em>in vitro</em>, the anti − oxidative part was identified as the ethyl acetate layer. A total of 24 chemical constituents were identified by liquid chromatography-mass spectrometry in the ethyl acetate layer and 13 main anti-oxidative active constituents were preliminarily screened out through off-line UPLC-QTOF-MS/MS-free radical scavenging. <em>In vivo</em> experiments showed that flowers of <em>X. sorbifolia</em> could significantly reduce the blood glucose level of diabetic mice and alleviate liver cell damage. Based on the results of docking analysis related to the identified phytocompounds and oxidase which involved in type 2 diabetes, quercetin 3-<em>O</em>-rutinoside, kaempferol-3-<em>O</em>-rhamnoside, isorhamnetin-3-<em>O</em>-glucoside, and isoquercitrin showed a better inhibitory profile.</p></div><div><h3>Conclusion</h3><p>The ethyl acetate layer was rich in flavonoids and phenolic acids and had significant anti-oxidant activity, which could prevent hyperglycemia. This observed activity profile suggested <em>X. sorbifolia</em> flowers as a promising new source of tea to develop alternative natural anti-diabetic products with a high safety margin.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 1","pages":"Pages 151-161"},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423000576/pdfft?md5=db1a4cca68dc49c6336fbceb4c875315&pid=1-s2.0-S1674638423000576-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43642885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemical components in cultivated Cordyceps sinensis and their effects on fibrosis 人工冬虫夏草化学成分及其对纤维化的影响
IF 3.8 4区 医学
Chinese Herbal Medicines Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2022.11.008
Zhonghua Dong , Xiao Sun
{"title":"Chemical components in cultivated Cordyceps sinensis and their effects on fibrosis","authors":"Zhonghua Dong ,&nbsp;Xiao Sun","doi":"10.1016/j.chmed.2022.11.008","DOIUrl":"10.1016/j.chmed.2022.11.008","url":null,"abstract":"<div><h3>Objective</h3><p>Cultivated <em>Cordyceps sinensis</em> powder has been used as clinical drug and healthy food to nourish the lung and kidney, which solves the problem of serious shortage of wild <em>C. sinensis</em>. This study aims to explore the chemical components and compared their anti-fibrotic effects in cultivated <em>C. sinensis</em>.</p></div><div><h3>Methods</h3><p>Nucleosides, sterols and polysaccharides were separated and purified from cultivated <em>C. sinensis</em>, and analyzed by high performance liquid chromatography, gas chromatography-mass spectrometry and chemical chromogenic methods, respectively. In high glucose-induced rat mesangial cell models, fibronectin and type 1 collagen were used as evaluation indicators.</p></div><div><h3>Results</h3><p>There were 10 kinds of nucleosides and one sterol in cultivated <em>C. sinensis</em>. The contents of nucleosides, sterols and polysaccharides in the cultivated <em>C. sinensis</em> were close to 2%, 0.55% and 4.4%, respectively. Furthermore, nucleoside, sterol and polysaccharide components exhibited varying degrees of anti-fibrotic activity. The nucleoside components and sterol components inhibited the expression of extracellular matrix more effectively in the three main components.</p></div><div><h3>Conclusion</h3><p>Cultivated <em>C. sinensis</em> remains the similar compounds with the wild <em>C. sinensis</em>, and nucleosides and sterols may be the main active substances that contribute to its anti-fibrotic effects. The project of this study may provide valuable information on further optimization of more effective remedies with few side effects based on cultivated <em>C. sinensis</em>.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 1","pages":"Pages 162-167"},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423000552/pdfft?md5=319177d3f4deaee59ed069f7d56fc30b&pid=1-s2.0-S1674638423000552-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41960117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Rhei Radix et Rhizoma and Eupolyphaga Steleophaga on liver protection mechanism based on pharmacokinetics and metabonomics 基于药代动力学和代谢组学的大黄和大戟对肝脏保护机制的影响
IF 3.8 4区 医学
Chinese Herbal Medicines Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.10.002
Gang Feng , Jianli Bi , Wenfang Jin , Qi Wang , Zhaokui Dan , Baolei Fan
{"title":"Effect of Rhei Radix et Rhizoma and Eupolyphaga Steleophaga on liver protection mechanism based on pharmacokinetics and metabonomics","authors":"Gang Feng ,&nbsp;Jianli Bi ,&nbsp;Wenfang Jin ,&nbsp;Qi Wang ,&nbsp;Zhaokui Dan ,&nbsp;Baolei Fan","doi":"10.1016/j.chmed.2023.10.002","DOIUrl":"10.1016/j.chmed.2023.10.002","url":null,"abstract":"<div><h3>Objective</h3><p>Based on metabonomics technology of high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS) and hydrogen nuclear magnetic resonance spectroscopy (<sup>1</sup>H NMR), the pharmacokinetic characteristics and therapeutic mechanism of <em>Rhei Radix</em> et <em>Rhizoma</em> (RhRR, Dahuang in Chinese), <em>Eupolyphaga Steleophaga</em> (EuS, Tubiechong in Chinese) combined with RhRR acting on acute liver injury were explored.</p></div><div><h3>Methods</h3><p>Models of acute liver injury were established, and the pharmacokinetic methods of five components of RhRR-EuS in rats were found by HPLC-MS/MS. The liver tissues of different groups of mice were analyzed by <sup>1</sup>H NMR spectroscopy combined with multivariate statistical analysis to investigate the metabolomics of RhRR-EuS and RhRR.</p></div><div><h3>Results</h3><p>Pharmacokinetic results showed there were different levels of bimodal phenomenon in different groups, and the absorption of free anthraquinone in RhRR increased after compatibility with EuS. In addition, the pathological state of acute liver injury in rats can selectively promote the absorption of emodin, chrysophanol, physcion and aloe emodin. Through 15 differential metabolites in the liver tissue of acute liver injury mice, it was revealed that RhRR-EuS and RhRR could protect the liver injury by regulating the metabolism of glutamine and glutamic acid, alanine, aspartic acid and glutamic acid, and phosphoinositide. However, the regulation of RhRR was weaker than that of RhRR-EuS.</p></div><div><h3>Conclusion</h3><p>For the first time, we studied the pharmacokinetics and metabolomics differences of RhRR-EuS and RhRR in rats and mice with acute liver injury, in order to provide theoretical reference for clinical treatment of liver disease by DHZCP.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 1","pages":"Pages 121-131"},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001119/pdfft?md5=1debdb34e58fa20485efdba09b369365&pid=1-s2.0-S1674638423001119-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139020898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypoxia inducible factor-1α related mechanism and TCM intervention in process of early fracture healing 缺氧诱导因子-1α在骨折早期愈合过程中的相关机制与中医干预
IF 3.8 4区 医学
Chinese Herbal Medicines Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.09.006
Wenxian Zhang , Fusen Yang , Qikai Yan , Jiahui Li , Xiaogang Zhang , Yiwei Jiang , Jianye Dai
{"title":"Hypoxia inducible factor-1α related mechanism and TCM intervention in process of early fracture healing","authors":"Wenxian Zhang ,&nbsp;Fusen Yang ,&nbsp;Qikai Yan ,&nbsp;Jiahui Li ,&nbsp;Xiaogang Zhang ,&nbsp;Yiwei Jiang ,&nbsp;Jianye Dai","doi":"10.1016/j.chmed.2023.09.006","DOIUrl":"https://doi.org/10.1016/j.chmed.2023.09.006","url":null,"abstract":"<div><p>As a common clinical disease, fracture is often accompanied by pain, swelling, bleeding as well as other symptoms and has a high disability rate, even threatening life, seriously endangering patients’ physical and psychological health and quality of life. Medical practitioners take many strategies for the treatment of fracture healing, including Traditional Chinese Medicine (TCM). In the early stage of fracture healing, the local fracture is often in a state of hypoxia, accompanied by the expression of hypoxia inducible factor-1α (HIF-1α), which is beneficial to wound healing. Through literature mining, we thought that hypoxia, HIF-1α and downstream factors affected the mechanism of fracture healing, as well as dominated this process. Therefore, we reviewed the local characteristics and related signaling pathways involved in the fracture healing process and summarized the intervention of TCM on these mechanisms, in order to inspirit the new strategy for fracture healing, as well as elaborate on the possible principles of TCM in treating fractures based on the HIF molecular mechanism.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 1","pages":"Pages 56-69"},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001090/pdfft?md5=a96bbfc2243d898f365d9f56fad6f10f&pid=1-s2.0-S1674638423001090-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139714504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Xiaoyao San on exercise capacity and liver mitochondrial metabolomics in rat depression model 小枣散对抑郁模型大鼠运动能力和肝线粒体代谢组学的影响
IF 3.8 4区 医学
Chinese Herbal Medicines Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.09.004
Weidi Zhao , Cui Ji , Jie Zheng , Shi Zhou , Junsheng Tian , Yumei Han , Xuemei Qin
{"title":"Effects of Xiaoyao San on exercise capacity and liver mitochondrial metabolomics in rat depression model","authors":"Weidi Zhao ,&nbsp;Cui Ji ,&nbsp;Jie Zheng ,&nbsp;Shi Zhou ,&nbsp;Junsheng Tian ,&nbsp;Yumei Han ,&nbsp;Xuemei Qin","doi":"10.1016/j.chmed.2023.09.004","DOIUrl":"10.1016/j.chmed.2023.09.004","url":null,"abstract":"<div><h3>Objective</h3><p>This study aimed to investigate the therapeutic effects of Xiaoyao San (XYS), a herbal medicine formula, on exercise capacity and liver mitochondrial metabolomics in a rat model of depression induced by chronic unpredictable mild stress (CUMS).</p></div><div><h3>Methods</h3><p>A total of 24 male SD rats were randomly divided into four groups: control group (C), CUMS control group (M), Venlafaxine positive treatment group (V), and XYS treatment group (X). Depressive behaviour and exercise capacity of rats were assessed by body weight, sugar-water preference test, open field test, pole test, and rotarod test. The liver mitochondria metabolomics were analyzed by using liquid chromatography-mass spectrometry (LC-MS) method. TCMSP database and GeneCards database were used to screen XYS for potential targets for depression, and GO and KEGG enrichment analyses were performed.</p></div><div><h3>Results</h3><p>Compared with C group, rats in M group showed significantly lower body weight, sugar water preference rate, number of crossing and rearing in the open field test, climbing down time in the pole test, and retention time on the rotarod test (<em>P</em> &lt; 0.01). The above behaviors and exercise capacity indices were significantly modulated in rats in V and X groups compared with M group (<em>P</em> &lt; 0.05, 0.01). Compared with C group, a total of 18 different metabolites were changed in the liver mitochondria of rats in M group. Nine different metabolites and six metabolic pathways were regulated in the liver mitochondria of rats in X group compared with M group. The results of network pharmacology showed that 88 intersecting targets for depression and XYS were obtained, among which 15 key targets such as IL-1β, IL-6, and TNF were predicted to be the main differential targets for the treatment of depression. Additionally, a total of 1 553 GO signaling pathways and 181 KEGG signaling pathways were identified, and the main biological pathways were AGE-RAGE signaling pathway, HIF-1 signaling pathway, and calcium signaling pathway.</p></div><div><h3>Conclusion</h3><p>XYS treatment could improve depressive symptoms, enhance exercise capacity, positively regulate the changes of mitochondrial metabolites and improve energy metabolism in the liver of depressed rats. These findings suggest that XYS exerts antidepressant effects through multi-target and multi-pathway.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 1","pages":"Pages 132-142"},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001053/pdfft?md5=25e4dd637e588532f906c703ab9c5f4f&pid=1-s2.0-S1674638423001053-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138609706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential efficacy and mechanism of eight mild-natured and bitter-flavored TCMs based on gut microbiota: A review 基于肠道微生物群的八种性味平和、味苦的中药的潜在疗效和作用机制综述
IF 3.8 4区 医学
Chinese Herbal Medicines Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.08.001
Wenquan Su , Yanan Yang , Xiaohui Zhao , Jiale Cheng , Yuan Li , Shengxian Wu , Chongming Wu
{"title":"Potential efficacy and mechanism of eight mild-natured and bitter-flavored TCMs based on gut microbiota: A review","authors":"Wenquan Su ,&nbsp;Yanan Yang ,&nbsp;Xiaohui Zhao ,&nbsp;Jiale Cheng ,&nbsp;Yuan Li ,&nbsp;Shengxian Wu ,&nbsp;Chongming Wu","doi":"10.1016/j.chmed.2023.08.001","DOIUrl":"10.1016/j.chmed.2023.08.001","url":null,"abstract":"<div><p>The mild-natured and bitter-flavored traditional Chinese medicines (MB-TCMs) are an important class of TCMs that have been widely used in clinical practice and recognized as safe long-term treatments for chronic diseases. However, as an important class of TCMs, the panorama of pharmacological effects and the mechanisms of MB-TCMs have not been systemically reviewed. Compelling studies have shown that gut microbiota can mediate the therapeutic activity of TCMs and help to elucidate the core principles of TCM medicinal theory. In this systematic review, we found that MB-TCMs commonly participated in the modulation of metabolic syndrome, intestinal inflammation, nervous system disease and cardiovascular system disease in association with promoting the growth of beneficial bacteria <em>Bacteroides</em>, <em>Akkermansia</em>, <em>Lactobacillus</em>, <em>Bifidobacterium</em>, <em>Roseburia</em> as well as inhibiting the proliferation of harmful bacteria <em>Helicobacter</em>, <em>Enterococcus</em>, <em>Desulfovibrio</em> and <em>Escherichia-Shigella</em>. These alterations, correspondingly, enhance the generation of protective metabolites, mainly including short-chain fatty acids (SCFAs), bile acid (BAs), 5-hydroxytryptamine (5-HT), indole and gamma-aminobutyric acid (GABA), and inhibit the generation of harmful metabolites, such as proinflammatory factors trimethylamine oxide (TAMO) and lipopolysaccharide (LPS), to further exert multiplicative effects for the maintenance of human health through several different signaling pathways. Altogether, this present review has attempted to comprehensively summarize the relationship between MB-TCMs and gut microbiota by establishing the TCMs-gut microbiota-metabolite-signaling pathway-diseases axis, which may provide new insight into the study of TCM medicinal theories and their clinical applications.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 1","pages":"Pages 42-55"},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001077/pdfft?md5=086c0458eea82486fd36d89f25b2ec44&pid=1-s2.0-S1674638423001077-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139016776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemical composition and pharmacological activity of seco-prezizaane-type sesquiterpenes seco-prezizaane-类型倍半萜的化学成分和药理活性
IF 3.8 4区 医学
Chinese Herbal Medicines Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.06.003
Ye Jin , Yanqing Xie , Peng Zhang , Afsar Khan , Zhihong Zhou , Lu Liu
{"title":"Chemical composition and pharmacological activity of seco-prezizaane-type sesquiterpenes","authors":"Ye Jin ,&nbsp;Yanqing Xie ,&nbsp;Peng Zhang ,&nbsp;Afsar Khan ,&nbsp;Zhihong Zhou ,&nbsp;Lu Liu","doi":"10.1016/j.chmed.2023.06.003","DOIUrl":"10.1016/j.chmed.2023.06.003","url":null,"abstract":"<div><p>The seco-prezizaane-type sesquiterpenes (SPS), as a special class of sesquiterpenes with a highly oxidative five-ring cage structure and seven consecutive chiral centers, are isolated from the genus <em>Illicium</em>, which have a variety of biological activities, including neurotoxicity and neurotrophic effects, etc. This review summarizes the chemical constituents and pharmacological effects of SPS, and discusses the potential trend and scope of future research.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 1","pages":"Pages 70-81"},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001065/pdfft?md5=b3ce3d2391ed5c6b301c5620be1bb9fa&pid=1-s2.0-S1674638423001065-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139018931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway 川芎提取物通过靶向 CTCF-c-MYC-H19 通路预防肝纤维化
IF 3.8 4区 医学
Chinese Herbal Medicines Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.07.003
Yajing Li , Fanghong Li , Mingning Ding , Zhi Ma , Shuo Li , Jiaorong Qu , Xiaojiaoyang Li
{"title":"Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway","authors":"Yajing Li ,&nbsp;Fanghong Li ,&nbsp;Mingning Ding ,&nbsp;Zhi Ma ,&nbsp;Shuo Li ,&nbsp;Jiaorong Qu ,&nbsp;Xiaojiaoyang Li","doi":"10.1016/j.chmed.2023.07.003","DOIUrl":"10.1016/j.chmed.2023.07.003","url":null,"abstract":"<div><h3>Objective</h3><p>Hepatic fibrosis has been widely considered as a conjoint consequence of almost all chronic liver diseases. <em>Chuanxiong Rhizoma</em> (Chuanxiong in Chinese, CX) is a traditional Chinese herbal product to prevent cerebrovascular, gynecologic and hepatic diseases. Our previous study found that CX extracts significantly reduced collagen contraction force of hepatic stellate cells (HSCs). Here, this study aimed to compare the protection of different CX extracts on bile duct ligation (BDL)-induced liver fibrosis and investigate plausible underlying mechanisms.</p></div><div><h3>Methods</h3><p>The active compounds of CX extracts were identified by high performance liquid chromatography (HPLC). Network pharmacology was used to determine potential targets of CX against hepatic fibrosis. Bile duct hyperplasia and liver fibrosis were evaluated by serologic testing and histopathological evaluation. The expression of targets of interest was determined by quantitative real-time PCR (qPCR) and Western blot.</p></div><div><h3>Results</h3><p>Different CX extracts were identified by tetramethylpyrazine, ferulic acid and senkyunolide A. Based on the network pharmacological analysis, 42 overlap targets were obtained via merging the candidates targets of CX and liver fibrosis. Different aqueous, alkaloid and phthalide extracts of CX (CX<sub>AE</sub>, CX<sub>AL</sub> and CX<sub>PHL</sub>) significantly inhibited diffuse severe bile duct hyperplasia and thus suppressed hepatic fibrosis by decreasing CCCTC binding factor (CTCF)-c-MYC-long non-coding RNA H19 (H19) pathway in the BDL-induced mouse model. Meanwhile, CX extracts, especially CX<sub>AL</sub> and CX<sub>PHL</sub> also suppressed CTCF-c-MYC-H19 pathway and inhibited ductular reaction in cholangiocytes stimulated with taurocholate acid (TCA), lithocholic acid (LCA) and transforming growth factor beta (TGF-<em>β</em>), as illustrated by decreased bile duct proliferation markers.</p></div><div><h3>Conclusion</h3><p>Our data supported that different CX extracts, especially CX<sub>AL</sub> and CX<sub>PHL</sub> significantly alleviated hepatic fibrosis and bile duct hyperplasia via inhibiting CTCF-c-MYC-H19 pathway, providing novel insights into the anti-fibrotic mechanism of CX.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 1","pages":"Pages 82-93"},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S167463842300103X/pdfft?md5=d8ba39991875e90c9cb536337c0c8aac&pid=1-s2.0-S167463842300103X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139291440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategies on biosynthesis and production of bioactive compounds in medicinal plants 药用植物中生物活性物质的合成与生产策略
IF 3.8 4区 医学
Chinese Herbal Medicines Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.01.007
Miaoxian Guo , Haizhou Lv , Hongyu Chen , Shuting Dong , Jianhong Zhang , Wanjing Liu , Liu He , Yimian Ma , Hua Yu , Shilin Chen , Hongmei Luo
{"title":"Strategies on biosynthesis and production of bioactive compounds in medicinal plants","authors":"Miaoxian Guo ,&nbsp;Haizhou Lv ,&nbsp;Hongyu Chen ,&nbsp;Shuting Dong ,&nbsp;Jianhong Zhang ,&nbsp;Wanjing Liu ,&nbsp;Liu He ,&nbsp;Yimian Ma ,&nbsp;Hua Yu ,&nbsp;Shilin Chen ,&nbsp;Hongmei Luo","doi":"10.1016/j.chmed.2023.01.007","DOIUrl":"10.1016/j.chmed.2023.01.007","url":null,"abstract":"<div><p>Medicinal plants are a valuable source of essential medicines and herbal products for healthcare and disease therapy. Compared with chemical synthesis and extraction, the biosynthesis of natural products is a very promising alternative for the successful conservation of medicinal plants, and its rapid development will greatly facilitate the conservation and sustainable utilization of medicinal plants. Here, we summarize the advances in strategies and methods concerning the biosynthesis and production of natural products of medicinal plants. The strategies and methods mainly include genetic engineering, plant cell culture engineering, metabolic engineering, and synthetic biology based on multiple “OMICS” technologies, with paradigms for the biosynthesis of terpenoids and alkaloids. We also highlight the biosynthetic approaches and discuss progress in the production of some valuable natural products, exemplifying compounds such as vindoline (alkaloid), artemisinin and paclitaxel (terpenoids), to illustrate the power of biotechnology in medicinal plants.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 1","pages":"Pages 13-26"},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423000734/pdfft?md5=e7c0c5117f521c86ee9c1aa10033f232&pid=1-s2.0-S1674638423000734-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46917564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus statement on research and application of Chinese herbal medicine derived extracellular vesicles-like particles (2023 edition) 中药提取细胞外囊泡样颗粒的研究与应用共识声明(2023年版)
IF 3.8 4区 医学
Chinese Herbal Medicines Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.11.002
Qing Zhao , Tong Wang , Hongbin Wang , Peng Cao , Chengyu Jiang , Hongzhi Qiao , Lihua Peng , Xingdong Lin , Yunyao Jiang , Honglei Jin , Huantian Zhang , Shengpeng Wang , Yang Wang , Ying Wang , Xi Chen , Junbing Fan , Bo Li , Geng Li , Bifeng Liu , Zhiyang Li , Kewei Zhao
{"title":"Consensus statement on research and application of Chinese herbal medicine derived extracellular vesicles-like particles (2023 edition)","authors":"Qing Zhao ,&nbsp;Tong Wang ,&nbsp;Hongbin Wang ,&nbsp;Peng Cao ,&nbsp;Chengyu Jiang ,&nbsp;Hongzhi Qiao ,&nbsp;Lihua Peng ,&nbsp;Xingdong Lin ,&nbsp;Yunyao Jiang ,&nbsp;Honglei Jin ,&nbsp;Huantian Zhang ,&nbsp;Shengpeng Wang ,&nbsp;Yang Wang ,&nbsp;Ying Wang ,&nbsp;Xi Chen ,&nbsp;Junbing Fan ,&nbsp;Bo Li ,&nbsp;Geng Li ,&nbsp;Bifeng Liu ,&nbsp;Zhiyang Li ,&nbsp;Kewei Zhao","doi":"10.1016/j.chmed.2023.11.002","DOIUrl":"10.1016/j.chmed.2023.11.002","url":null,"abstract":"<div><p>To promote the development of extracellular vesicles of herbal medicine especially the establishment of standardization, led by the National Expert Committee on Research and Application of Chinese Herbal Vesicles, research experts in the field of herbal medicine and extracellular vesicles were invited nationwide with the support of the Expert Committee on Research and Application of Chinese Herbal Vesicles, Professional Committee on Extracellular Vesicle Research and Application, Chinese Society of Research Hospitals and the Guangdong Engineering Research Center of Chinese Herbal Vesicles. Based on the collation of relevant literature, we have adopted the Delphi method, the consensus meeting method combined with the nominal group method to form a discussion draft of “Consensus statement on research and application of Chinese herbal medicine derived extracellular vesicles-like particles (2023)”. The first draft was discussed in online and offline meetings on October 12, 14, November 2, 2022 and April and May 2023 on the current status of research, nomenclature, isolation methods, quality standards and research applications of extracellular vesicles of Chinese herbal medicines, and 13 consensus opinions were finally formed. At the Third Academic Conference on Research and Application of Chinese Herbal Vesicles, held on May 26, 2023, Kewei Zhao, convenor of the consensus, presented and read the consensus to the experts of the Expert Committee on Research and Application of Chinese Herbal Vesicles. The consensus highlights the characteristics and advantages of Chinese medicine, inherits the essence, and keeps the righteousness and innovation, aiming to provide a reference for colleagues engaged in research and application of Chinese herbal vesicles at home and abroad, decode the mystery behind Chinese herbal vesicles together, establish a safe, effective and controllable accurate Chinese herbal vesicle prevention and treatment system, and build a bridge for Chinese medicine to the world.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 1","pages":"Pages 3-12"},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001107/pdfft?md5=bf5fe2945fabc69995f27c440126c3db&pid=1-s2.0-S1674638423001107-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138991419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信